Intrinsic value of First Trust/Confluence Small Cap Value Fund (FOVAX)
Live fair value data for First Trust/Confluence Small Cap Value Fund (FOVAX) is currently unavailable. Please check again shortly.
Current Price: $248.00
Valuation: Undervalued
Confidence: 9.5/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is First Trust/Confluence Small Cap Value Fund (FOVAX) undervalued or overvalued?
Based on the current model output, First Trust/Confluence Small Cap Value Fund appears to be undervalued with a upside of 56.00%.
Fair value vs market price — First Trust/Confluence Small Cap Value Fund (FOVAX)
Unlock premium access to view the live fair value comparison against current market price for FOVAX.
Frequently Asked Questions - FOVAX
How is FOVAX intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for FOVAX.
Is FOVAX undervalued or overvalued right now?
FOVAX is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for FOVAX: open their intrinsic value pages.
- FFord Motor Company
- RYLCXRydex Leisure Fund Class C
- VVisa Inc.
- HNRGXHennessy Energy Transition Fund Investor Class
- GWILXGlenmede Women in Leadership US Eq
- EMQAXAshmore Emerging Markets Active Equity Fund - Class A
- GOPIXAberdeen China A Share Equity Fund Institutional Class
- HBFBXHennessy Balanced Fund Investor Class